May 5, 2000 -- Women will soon have another choice when it comes to unwanted
pregnancies. The forthcoming drug, Mifeprex (mifepristone, formerly known in
Europe as RU-486), offers women a medical abortion without the need for
surgery. The Food and Drug Administration (FDA) is expected to approve the drug
in the next few months.
Advocates of Mifeprex and other medical abortion drugs are hopeful that this
new option will continue to fuel the trend of women making choices early on.
"Any type of abortion that is performed in the first seven weeks of a
pregnancy is extremely safe, but with medical abortions there's no anesthesia
necessary and no surgery," says Richard Hausknecht, MD, a professor at
Mount Sinai School of Medicine.
By Amy Engeler
At 3 a.m., with all the houses dark up and down her winding suburban street in West Warwick, Rhode Island, Jo-Ann Frey, 37, lights a candle so she can see well enough to dust her furniture. Careful not to turn on any lights or make noise that might wake up her family, she drifts from room to room with her candle and cleaning supplies, waiting until she feels sleepy enough to climb back into bed. That feeling doesn't come -- and when she hears the alarm in the bedroom go off...
Hausknecht has been performing abortions in the United States since 1970,
when they were first legalized. "The earlier the abortion is performed, the
better," he says. "Medical abortions can be performed as soon as a
woman knows she's pregnant, whereas most abortion clinics have women wait until
they are at least seven weeks pregnant before performing a surgical abortion --
though a well-trained doctor can perform one at five weeks."
For years Hausknecht has been using methotrexate (which terminates the
pregnancy) and misoprostol (which causes the uterus to contract), drugs that
are not approved by the FDA for medical abortion, but are used off-label for
that very purpose.
Why are abortion providers anxious for the FDA to approve Mifeprex if other
drugs like it are already in use? It's not that the drug is safer, Hausknecht
says. Women are at no lower risk from a medical versus a surgical procedure.
But women prefer the noninvasive approach. "It's private," he says.
"We extensively counsel a woman about what she can expect. She takes the
drugs in our office, and then she goes home."
Another advantage to Mifeprex is that doctors can predict with greater
accuracy when the spontaneous pregnancy loss will occur. In 50% of the cases,
it's within four hours of taking the drug. In addition, "many physicians
are leery of using drugs that are not FDA-approved, especially when it comes to
such a controversial procedure as abortion," Hausknecht says.